自1974年本药滴眼剂问世以来,临床应用的广泛观察,证实可降低正常人和慢性开角型青光眼的眼压。本文係作者们继1978年他们的报告以后,将治疗对象从慢性开角型青光眼扩大到一般眼压高(视野和视神经乳头正常)和无晶体眼青 Since the advent of this medicine eye drops in 1974, extensive clinical application has been shown to reduce the intraocular pressure in normal subjects and chronic open-angle glaucoma. In this article, the authors, following their report in 1978, expanded the treatment of patients with chronic open-angle glaucoma to general high intraocular pressure (visual field and optic nerve head normal) and aphakia